Abstract | PURPOSE: METHODS: A total of 430 patients with breast cancer treated between 2006 and 2013 were retrospectively reviewed; of these, 123 cases were considered TNBC (n=71; 58%) or were positive for HER2 (n=52; 42%). Mesothelin expression was assessed by immunohistochemistry. RESULTS: Of the patients with TNBC, 30 (42.3%) were positive for mesothelin expression, compared to only two (3.8%) of the HER2-positive cases. As most HER2-positive tumors were negative for mesothelin staining, statistical analysis was not performed. Median overall survival (OS) was 70.1 months for patients with TNBC, whereas median OS was 70.1 months, in the mesothelin-positive group and 74.5 months in mesothelin-negative group, respectively. Strong correlation was seen between mesothelin expression and tumor grade in patients with TNBC (P<0.005). In a multivariable Cox proportional hazards model, mesothelin expression was not independently associated with OS in patients with TNBC. CONCLUSIONS: Expression of mesothelin was observed in 42.3% of patients with TNBC and demonstrated a strong association with tumor grade. However, its expression was not correlated with prognosis.
|
Authors | Ibrahim Vedat Bayoglu, Betul Bolat Kucukzeybek, Yuksel Kucukzeybek, Umut Varol, Ibrahim Yildiz, Ahmet Alacacioglu, Murat Akyol, Lutfiye Demir, Ahmet Dirican, Yasar Yildiz, Tarik Salman, Mustafa Oktay Tarhan |
Journal | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
(Biomed Pharmacother)
Vol. 70
Pg. 190-5
(Mar 2015)
ISSN: 1950-6007 [Electronic] France |
PMID | 25776500
(Publication Type: Journal Article)
|
Copyright | Copyright © 2015 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- GPI-Linked Proteins
- ERBB2 protein, human
- Receptor, ErbB-2
- Mesothelin
|
Topics |
- Adult
- Biomarkers, Tumor
(biosynthesis)
- Breast Neoplasms
(diagnosis, metabolism, mortality)
- Female
- GPI-Linked Proteins
(biosynthesis)
- Humans
- Mesothelin
- Middle Aged
- Prognosis
- Receptor, ErbB-2
- Survival Rate
(trends)
- Triple Negative Breast Neoplasms
(diagnosis, metabolism, mortality)
|